Nanalysis Scientific Corp (NSCI) — Capital Reinvestment Ratio
Latest as of December 2025:
0.19x
Nanalysis Scientific Corp (NSCI) has a Capital Reinvestment Ratio of 0.19x as of December 2025, meaning it reinvests 0% of its operating cash flow (CA$2.65 Million) in capital expenditures (CA$505.00K). See cash generation quality of Nanalysis Scientific Corp to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.19x
Capex / Operating Cash Flow
Operating Cash Flow
CA$2.65 Million
CAD
Capital Expenditures
CA$505.00K
CAD
Data as of
Dec 2025
Most recent filing
Nanalysis Scientific Corp Capital Reinvestment Ratio (2016–2025)
This chart tracks Nanalysis Scientific Corp's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Nanalysis Scientific Corp (2016–2025)
Year-by-year Capital Reinvestment Ratio for Nanalysis Scientific Corp from 2016 to 2025. For live market cap and broader valuation context, see Nanalysis Scientific Corp (NSCI) total market value.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.55x | CA$3.45 Million | CA$1.88 Million | ▼ -4.2% |
| 2024 | 0.57x | CA$3.26 Million | CA$1.86 Million | ▼ -18.4% |
| 2019 | 0.70x | CA$781.00K | CA$545.00K | ▲ +650.1% |
| 2017 | 0.09x | CA$1.40 Million | CA$130.66K | ▼ -90.6% |
| 2016 | 0.99x | CA$593.74K | CA$587.91K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow